Article Details

Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy ...

Retrieved on: 2021-05-19 12:08:40

Tags for this article:

Click the tags to see associated articles and topics

Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy .... View article details on hiswai:

Excerpt

The GEMINI phase 1, randomized, double-blind, placebo-controlled, ... filed with the U.S. Securities and Exchange Commission on April 29, 2021.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up